Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
145.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (2.847%)
Market Cap: £113.79m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Statement-COVID-19 & Preliminary Statement

23 Mar 2020 17:47

RNS Number : 2844H
Xaar PLC
23 March 2020
 

Xaar plc

 

Trading update and revised date for full year results 

 

Xaar plc ("Xaar" or the "Group"), the leading inkjet printing technology Group, announces a confirmation of previous guidance and a revised date for the presentation of full year results.

 

Full year results

 

Preliminary financial statements for the 12 months ended 31 December 2019 were scheduled to be released 24 March 2020.

 

The FCA has strongly requested all listed companies observe a moratorium on the publication of preliminary financial statements for at least two weeks.

 

In compliance with this request, Xaar will not be releasing preliminary financial statements, but will publish full audited financial statements within four months of the financial year end, subject to any further guidance from the FCA.

 

Trading update

 

Xaar continues to make good progress with its strategy and re-iterates the preliminary guidance for 2019:

 

The Group expects to report revenues for its continuing operations of £49.4 million for the year ended 31 December 2019.

 

Group cash balances (including cash held for investment in Xaar 3D) were £25.3 million at 31 December 2019.

 

COVID19 - Update

 

The health, safety and security of our employees is our upmost priority and appropriate actions have been taken to our operational procedures to mitigate risk.

 

The Group's trading performance in 2020 to date has been in line with expectations. No orders have been cancelled, however we are mindful of the rapidly changing environment in which the business is operating.

 

While the full implications of COVID-19 on the financial performance for the current financial year are difficult to determine at this stage, the Board remains confident in the long-term prospects of the Group.

 

 

Enquiries:

Xaar plc

+44 (0)1223 423 663 

John Mills, Chief Executive Officer

Ian Tichias, Chief Finance Officer

 

 

Tulchan Communications

+44 (0)20 7353 4200

James Macey White

Giles Kernick

Hollie Ralston

 

About XaarXaar is a world leader in the development of digital inkjet technology. Our technology drives the conversion of analogue printing and manufacturing methods to digital inkjet which is more efficient, more economical and more productive than the traditional methods which have been in use for years. We design and manufacture printheads as well as systems for product decoration and industrial 3D Printing which use our inkjet technology. We are the only truly independent inkjet technology company with over 25 years of know how. We offer unrivalled inkjet expertise including technology and printhead design and development and manufacture highly customised product decoration systems and industrial 3D Printing for volume manufacturing. Our unique technologies and products are the leading enabler for innovation and for driving supply chain efficiencies for many industries. Information about Xaar is at www.xaar.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTPPUQCWUPUGMW
Date   Source Headline
4th Jul 20143:06 pmRNSHolding(s) in Company
4th Jul 20143:01 pmRNSHolding(s) in Company
3rd Jul 20149:41 amRNSHolding(s) in Company
1st Jul 201410:38 amRNSTotal Voting Rights
1st Jul 201410:38 amRNSBlocklisting Interim Review
27th Jun 201411:31 amRNSHolding(s) in Company
25th Jun 20145:53 pmRNSHolding(s) in Company
25th Jun 20147:00 amRNSDirector/PDMR Shareholding
24th Jun 20145:05 pmRNSDirector/PDMR Shareholding
20th Jun 20144:13 pmRNSHolding(s) in Company
20th Jun 201410:36 amRNSHolding(s) in Company
20th Jun 201410:19 amRNSHolding(s) in Company
17th Jun 20147:00 amRNSTrading Update
13th Jun 20147:00 amRNSAppointment of Corporate Broker
2nd Jun 20144:00 pmRNSTotal Voting Rights
14th May 20146:10 pmRNSResult of AGM
13th May 20147:00 amRNSGrant of Options
12th May 20145:58 pmRNSDirector/PDMR Shareholding
1st May 201412:10 pmRNSTotal Voting Rights
30th Apr 201411:35 amRNSDirector/PDMR Shareholding
24th Apr 20147:00 amRNSDirector/PDMR Shareholding
23rd Apr 201410:08 amRNSNotice of 2014 AGM & Annual Financial Report
22nd Apr 20144:31 pmRNSDirector/PDMR Shareholding
17th Apr 201412:39 pmRNSDirector/PDMR Shareholding - Replacement
17th Apr 201412:08 pmRNSDirector/PDMR Shareholding
17th Apr 201411:20 amRNSDirector/PDMR Shareholding
16th Apr 20147:00 amRNSXaar plc - Interim Management Statement
10th Apr 20145:40 pmRNSHolding(s) in Company
4th Apr 201411:31 amRNSDirector/PDMR Shareholding
4th Apr 20149:13 amRNSGrant of Options
1st Apr 20149:25 amRNSTotal Voting Rights
28th Mar 20147:02 amRNSDirector/PDMR Shareholding
19th Mar 20143:58 pmRNSDirector/PDMR Shareholding
18th Mar 20147:00 amRNS2013 Full Year Results
13th Mar 20147:00 amRNSXaar plc - XAAR LAUNCHES THE XAAR 1002
28th Feb 201411:57 amRNSTotal Voting Rights
7th Feb 201410:42 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSTrading Statement
7th Jan 20147:00 amRNSBlocklisting Interim Review
2nd Jan 201411:26 amRNSTotal Voting Rights
23rd Dec 20131:47 pmRNSHolding(s) in Company
16th Dec 20133:48 pmRNSHolding(s) in Company
13th Dec 20134:34 pmRNSHolding(s) in Company
13th Dec 20139:23 amRNSHolding(s) in Company
4th Dec 20133:28 pmRNSHolding(s) in Company
4th Dec 20132:20 pmRNSHolding(s) in Company
2nd Dec 20137:00 amRNSDirector/PDMR Shareholding
31st Oct 20134:37 pmRNSTotal Voting Rights
28th Oct 20134:21 pmRNSHolding(s) in Company
17th Oct 20137:00 amRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.